Using Technology to Reduce Monitoring Costs and Increase Quality

Current clinical trial methods for collecting, managing and monitoring site data are inefficient, outdated and cumbersome. By leveraging direct data capture technologies, sponsors can reduce monitoring and data management costs significantly — by as much as 30 percent or more — according to the expert speakers’ analysis.

In this webinar, the speakers will discuss the benefits of moving from the traditional industry model to an eSource model where the sites capture data electronically as source, which then becomes the electronic care report form (eCRF). This direct data capture (DDC) model eliminates the need for sites to transcribe data into a secondary EDC, and for Clinical Research Associates (CRAs) to perform most forms of source data verification. It enables a more agile, risk-based monitoring approach where data review can occur closer to data collection. Moreover, by centralizing and remote-enabling the monitoring, the DDC model improves the CRA’s productivity and retention.

The expert speakers will demonstrate how the cost of the technology license itself is only a small portion of the overall study budget — it is the operational efficiencies that technology enables where real savings can accrue. Moving from traditional EDC to DDC reduces the number of monitoring visits that need to occur, increases the amount of monitoring that can be done remotely and streamlines many of the processes and deliverables that data management platforms require.

Register for this webinar today to learn how direct data capture technologies are revolutionizing clinical trial data collection, management and monitoring.

Speakers

Robert Goldman, Consultant, ALCOA Consulting

With over 15 years of clinical research experience working at the site/CRO/sponsor level, Robert Goldman offers a unique blend of in-depth therapeutic and medical knowledge with extensive experience across dozens of therapeutic areas. His expertise spans a 360-degree view of clinical studies and trial operations, providing a comprehensive understanding that ensures the successful execution and completion of all phases of global clinical programs.

Message Presenter

Raymond Nomizu, Co-CEO, CRIO

Prior to co-founding CRIO, Raymond Nomizu owned and operated a clinical research site. He has over 10 years of management consulting experience, including at The Boston Consulting Group. He also started Bench Core, a real estate data analytics company that was acquired by RefineRE. He began his career as an attorney and has JD and BA degrees from Harvard University.

Message Presenter